May 26 (Reuters) - German researchers on Wednesday said that based on laboratory research, they believed they have found the cause of the rare but serious blood clotting events among some people who received COVID-19 vaccines made by AstraZeneca Plc and Johnson & Johnson.
The researchers, in a study not yet reviewed by experts, said COVID-19 vaccines that employ adenovirus vectors - cold viruses used to deliver vaccine material - send some of their payload into the nucleus of cells, where some of the instructions for making coronavirus proteins can be misread. The resulting proteins could potentially trigger blood clot disorders in a small number of recipients, they suggest.
Немецкие ученые нашли связь вакцины AstraZeneca с образованием тромбов
oane.ws - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from oane.ws Daily Mail and Mail on Sunday newspapers.
Dalla Germania nuova ipotesi per spiegare le trombosi anomale
zazoom.it - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from zazoom.it Daily Mail and Mail on Sunday newspapers.
На сайте RABOTA SUD UA собрана наиболее полная база предложений работы для юристов
sud.ua - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sud.ua Daily Mail and Mail on Sunday newspapers.
Germans SOLVE Covid vaccine blood clot puzzle: Scientists say rare side effect from AstraZeneca jabs is caused by cold virus used to deliver the jab into the body - and can be FIXED
Germans scientists say they have figured out why the Covid vaccines from AstraZeneca and Johnson & Johnson are linked to rare blood clots
In a new pre-print, the team says the problem is with the adenovirus vector, a common cold virus used to get the body to induce an immune response
They claim the vaccine is sent into the cell nucleus instead of surrounding fluid, where parts of it break off and create mutated versions of themselves